SE8702712D0 - Improvements in or relating to calcium salts - Google Patents

Improvements in or relating to calcium salts

Info

Publication number
SE8702712D0
SE8702712D0 SE8702712A SE8702712A SE8702712D0 SE 8702712 D0 SE8702712 D0 SE 8702712D0 SE 8702712 A SE8702712 A SE 8702712A SE 8702712 A SE8702712 A SE 8702712A SE 8702712 D0 SE8702712 D0 SE 8702712D0
Authority
SE
Sweden
Prior art keywords
relating
calcium salts
calcium
free
organic
Prior art date
Application number
SE8702712A
Other languages
English (en)
Other versions
SE8702712L (sv
SE502567C2 (sv
Inventor
J-M Gailly
D Gomez
M Burguiere
A Gens
J Remy
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of SE8702712D0 publication Critical patent/SE8702712D0/sv
Publication of SE8702712L publication Critical patent/SE8702712L/sv
Publication of SE502567C2 publication Critical patent/SE502567C2/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/10—Carbonates; Bicarbonates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SE8702712A 1986-07-01 1987-06-30 Farmaceutisk komposition innefattande kalciumsalter SE502567C2 (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8609515A FR2600893B1 (fr) 1986-07-01 1986-07-01 Nouvelles compositions pharmaceutiques a base de sels de calcium

Publications (3)

Publication Number Publication Date
SE8702712D0 true SE8702712D0 (sv) 1987-06-30
SE8702712L SE8702712L (sv) 1988-01-02
SE502567C2 SE502567C2 (sv) 1995-11-13

Family

ID=9336917

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8702712A SE502567C2 (sv) 1986-07-01 1987-06-30 Farmaceutisk komposition innefattande kalciumsalter

Country Status (31)

Country Link
US (1) US4867977A (sv)
JP (1) JPS6322522A (sv)
KR (1) KR950014449B1 (sv)
AT (1) AT392588B (sv)
AU (1) AU597992B2 (sv)
BE (1) BE1007686A4 (sv)
CA (1) CA1305057C (sv)
CH (1) CH674935A5 (sv)
CY (1) CY1684A (sv)
DE (1) DE3720510C2 (sv)
DK (1) DK173508B1 (sv)
ES (1) ES2006192A6 (sv)
FI (1) FI89329C (sv)
FR (1) FR2600893B1 (sv)
GB (1) GB2192131B (sv)
GR (1) GR871015B (sv)
HK (1) HK80393A (sv)
HU (1) HU199283B (sv)
IE (1) IE60430B1 (sv)
IL (1) IL83032A (sv)
IT (1) IT1216829B (sv)
LU (1) LU86932A1 (sv)
MY (1) MY101750A (sv)
NL (1) NL194749C (sv)
NO (1) NO175041B (sv)
NZ (1) NZ220898A (sv)
PH (1) PH25430A (sv)
PT (1) PT85212B (sv)
SE (1) SE502567C2 (sv)
SG (1) SG123192G (sv)
ZA (1) ZA874769B (sv)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH621486A5 (sv) * 1977-01-27 1981-02-13 Fischer Artur
JP2665764B2 (ja) * 1988-04-20 1997-10-22 日水製薬株式会社 カルシウム水溶液剤
EP0346866A3 (en) * 1988-06-16 1990-07-11 Biochemie Gesellschaft M.B.H. Composition for the prophylaxis of osteoporosis
CA2123604C (en) * 1991-12-26 1998-02-17 Alice Lyles Burkes Storage stable calcium-supplemented beverage concentrates
CA2146633C (en) * 1992-10-21 1998-09-01 Mark Benson Andon Concentrated bioavailable calcium source
WO1994008473A1 (en) * 1992-10-21 1994-04-28 The Procter & Gamble Company Storage stable calcium-supplemented beverage premix concentrates and syrups
AU5406094A (en) * 1992-10-21 1994-05-09 Procter & Gamble Company, The Sweetener containing a concentrated bioavailable calcium source
DE19503190A1 (de) * 1995-02-01 1996-08-08 Dietl Hans Mittel zur Beeinflussung von Störungen der Knochenbildung
US5942255A (en) * 1996-07-15 1999-08-24 The University Of Memphis Methods of enhancing lean tissue mass and bone mineral content and compositions therefor
US6235322B1 (en) * 1999-03-09 2001-05-22 Mintech, Inc. Highly soluble and stable mineral supplements containing calcium and magnesium
EP1516624B1 (en) * 2002-06-27 2009-03-11 Manuel Torres Buendia Method of producing calcium gluconolactate, compositions, processes and uses of same
US20040048925A1 (en) * 2002-09-09 2004-03-11 Wiley David B. Composition and method for enhancing the bioavailability of calcium and magnesium in dietary supplements and food additives
US20040106678A1 (en) * 2002-09-17 2004-06-03 Dobbins Thomas A Compositions for the parenteral administration of calcium and magnesium
CA2520197A1 (en) * 2003-04-23 2004-11-04 Ferring B.V. Sachet for a pharmaceutical composition
US20040258818A1 (en) * 2003-06-20 2004-12-23 Kraft Foods Holdings, Inc. Reduced acidic flavor in acidified starch products
US7198653B2 (en) 2003-07-31 2007-04-03 Delavau Llc Calcium carbonate granulation
WO2005021056A1 (en) * 2003-08-21 2005-03-10 Cns, Inc. Effervescent delivery system
US7323201B2 (en) * 2004-06-08 2008-01-29 Tate & Lyle Ingredients Americas, Inc. Highly soluble form of tricalcium citrate, and methods of its making and use
US9138414B1 (en) 2006-09-15 2015-09-22 Delavau Llc Calcium supplement having enhanced absorption
US20090298946A1 (en) * 2008-06-02 2009-12-03 Cleavelin Cody R Local Anesthetic Deactivation
WO2019126262A1 (en) * 2017-12-20 2019-06-27 Dsm Ip Assets B.V. Materials and methods for dietary calcium supplementation of animals
US20230000800A1 (en) * 2019-12-12 2023-01-05 Alberta Veterinary Laboratories Ltd. Choline bolus compositions for ruminants
CN113749205A (zh) * 2021-09-09 2021-12-07 山东凯翔生物科技股份有限公司 一种葡萄糖酸钙-葡萄糖酸复合粉的制备方法

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1526981A (en) * 1923-02-02 1925-02-17 Upjohn Co Effervescent alkali compound and process of manufacturing and preparing the same
US1616587A (en) * 1926-08-25 1927-02-08 Upjohn Co Method of manufacturing effervescent alkali compounds
US1765867A (en) * 1928-12-15 1930-06-24 Henry G Granger Method for making candy
US2603569A (en) * 1950-01-23 1952-07-15 Joseph G Alther Effervescent drink concentrate
US2639238A (en) * 1952-07-02 1953-05-19 Joseph G Alther Effervescent drink concentrate
US3082091A (en) * 1956-07-03 1963-03-19 Pierre F Smith Effervescing composition in particle form
US3061445A (en) * 1959-04-30 1962-10-30 Abbott Lab Effervescent sweetening tablet
US3105792A (en) * 1960-11-29 1963-10-01 Warner Lambert Pharmaceutical Stable effervescent compositions and method of preparing same
US3241977A (en) * 1962-01-02 1966-03-22 Gen Foods Corp Effervescent beverage powders
US3328304A (en) * 1964-07-31 1967-06-27 Guardian Chemical Corp Chelating agents and methods for their manufacture
US3489572A (en) * 1966-04-04 1970-01-13 Benjamin Eisenstadt Sweetening composition
BE760328A (fr) * 1969-12-15 1971-06-14 Sandoz Sa Nouvelle association medicamenteuse
US3965273A (en) * 1973-04-02 1976-06-22 General Foods Corporation Dry carbonation source and method for preparing the same, and dry carbonated beverage concentrate
US3939289A (en) * 1973-04-02 1976-02-17 General Foods Corporation Dry carbonation source for a beverage concentrate and method of preparing the same
US4237147A (en) * 1974-01-04 1980-12-02 Monsanto Company Stabilized amorphous calcium carbonate
US3949098A (en) * 1974-06-05 1976-04-06 Nabisco, Inc. Nutritious orange drink concentrate, process and drink resultant therefrom
US4009292A (en) * 1975-02-26 1977-02-22 General Foods Corporation Effervescent dipeptide sweetener tablets
US4206244A (en) * 1978-02-06 1980-06-03 Persian Delight, Inc. Dry mix for preparing a carbonated yogurt
JPS5585385A (en) * 1978-12-22 1980-06-27 Mitsuma Miyoshi Powdered food and drink
JPS57122925A (en) * 1981-01-26 1982-07-31 Ajinomoto Co Inc Tablet composition
US4551342A (en) * 1983-02-01 1985-11-05 The Procter & Gamble Company Beverages containing specific cation-edible acid mixtures for improved flavor impression
JPS59166057A (ja) * 1983-03-14 1984-09-19 Ajinomoto Co Inc ジペプチド甘味料含有発泡錠剤の製造法
US4678661A (en) * 1983-09-28 1987-07-07 Gerhard Gergely Effervescent composition and method of making same
US4725427A (en) * 1984-03-13 1988-02-16 Albion International, Inc. Effervescent vitamin-mineral granule preparation
US4647453A (en) * 1984-10-18 1987-03-03 Peritain, Ltd. Treatment for tissue degenerative inflammatory disease
US4760138A (en) * 1984-12-13 1988-07-26 Nestec S. A. Carbonating agents and their preparation
US4772467A (en) * 1985-02-19 1988-09-20 Board Of Regents, U T Systems Osteoporosis inhibition by dietary calcium supplementation
JPS62501843A (ja) * 1985-02-19 1987-07-23 ボ−ド・オブ・リ−ジェンツ・ザ・ユニバ−シティ−・オブ・テキサス・システム 食事のカルシウム補足によるオステオポロ−シス抑制
US4650669A (en) * 1985-07-30 1987-03-17 Miles Laboratories, Inc. Method to make effervescent calcium tablets and calcium tablets produced thereby

Also Published As

Publication number Publication date
IE60430B1 (en) 1994-07-13
DE3720510C2 (de) 2002-12-19
JPS6322522A (ja) 1988-01-30
SE8702712L (sv) 1988-01-02
AT392588B (de) 1991-04-25
PT85212A (en) 1987-07-01
DK173508B1 (da) 2001-01-15
ATA164187A (de) 1990-10-15
NO175041C (sv) 1994-08-24
LU86932A1 (fr) 1988-01-20
CH674935A5 (sv) 1990-08-15
SG123192G (en) 1993-02-19
BE1007686A4 (fr) 1995-10-03
PH25430A (en) 1991-07-01
FR2600893B1 (fr) 1990-01-12
HUT49481A (en) 1989-10-30
NL194749C (nl) 2003-02-04
HK80393A (en) 1993-08-13
NO175041B (no) 1994-05-16
FR2600893A1 (fr) 1988-01-08
IE871730L (en) 1988-01-01
IL83032A0 (en) 1987-12-20
DE3720510A1 (de) 1988-01-07
NL8701440A (nl) 1988-02-01
IT1216829B (it) 1990-03-14
AU597992B2 (en) 1990-06-14
DK333487D0 (da) 1987-06-29
GB2192131B (en) 1990-04-04
FI872871A (fi) 1988-01-02
CY1684A (en) 1993-10-10
IL83032A (en) 1991-05-12
NL194749B (nl) 2002-10-01
FI89329C (sv) 1993-09-27
DK333487A (da) 1988-01-02
NZ220898A (en) 1991-04-26
CA1305057C (en) 1992-07-14
ZA874769B (en) 1989-02-22
PT85212B (pt) 1990-03-30
GB2192131A (en) 1988-01-06
GR871015B (en) 1987-11-02
SE502567C2 (sv) 1995-11-13
AU7491387A (en) 1988-01-07
GB8715216D0 (en) 1987-08-05
HU199283B (en) 1990-02-28
KR950014449B1 (ko) 1995-11-28
IT8748100A0 (it) 1987-06-25
FI872871A0 (fi) 1987-06-29
MY101750A (en) 1992-01-17
NO872712D0 (no) 1987-06-29
FI89329B (fi) 1993-06-15
KR880001295A (ko) 1988-04-22
ES2006192A6 (es) 1989-04-16
NO872712L (no) 1988-01-04
US4867977A (en) 1989-09-19

Similar Documents

Publication Publication Date Title
SE8702712D0 (sv) Improvements in or relating to calcium salts
DE3686645T2 (de) Pharmazeutische zusammensetzungen zur verbesserung von wundheilung.
FI895342A0 (fi) Ibuprofen-brusprodukter.
SE8602405L (sv) Ny formulering
SE8702941L (sv) Farmaceutisk, n-acetyl-cysteininnehallande, vattenloslig komposition
FI854167L (fi) Mun- och tandvaordsmedel.
ATE73800T1 (de) Anhydrisches und kristallines natriumsalz von 5- chloro-3-(2-thenoyl)-2-oxindol-1-carboxamid.
DK131887D0 (da) 1,2,3,4-tetrahydro-3-carbamoyl-2-thioxo/oxo-5-pyrimidencarboxylsyre-derivater og deres anvendelse som laegemidler
DE3867445D1 (de) Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren.
PT90362A (pt) Metodo para o tratamento de doencas muco-epiteliais e da pele em mamiferos que utiliza acidos 4-quinolinocarboxilicos e seus derivados e processo para a preparacao de composicoes farmaceuticas que contem os mesmos compostos
LV5660A3 (lv) Panemiens pretvirusu lidzekla iegusanai
FI864503A0 (fi) Brandslaecknings- och impregneringsmedel mot brand.
OA07904A (fr) Composition nutritive de l'acide alpha-cétois un de ses sels.
FR2571366B1 (fr) Procede de preparation de la l-carnitine et de ses sels
DK179786D0 (da) (-)-1beta-ethyl-1alfa-hydroxylmethyl-1,2,3,4,6,7,12,12balfa-octa-hydroindolo(2,3-a)quinolizin og syreadditionssalte deraf, deres fremstilling og anvendelse som farmaceutika
SE7702078L (sv) Antibiotikom
DK401683D0 (da) Substituerede benzensulfonsyreestere, fremgangsmade til deres fremstilling og deres anvendelse som laegemidler
DK384785D0 (da) Optisk aktive, substituerede 1,4-dihydropyridiner eller syreadditionssalte deraf, deres fremstilling og anvendelse som calciumantagonister
GB2012163A (en) Composition for treating diarrhoea
DK544887A (da) Fremgangsmaade til fremstilling af betahydroxysmoersyre og dennes salte
DK299983D0 (da) Racemiske eller optisk aktive apovincaminsyrederivater eller farmaceutisk aktive syreadditionssalte deraf, deres fremstilling og anvendelse
DE3865642D1 (de) Pharmazeutische zubereitung zur cholelitholyse.
IS3148A7 (is) Aðferð til að framleiða ranitidine eða sýrubætandi sölt þess
IT1221510B (it) Composti di cefalosporina,procedimento per produrli e composizioni farmaceutiche che li contengono
DE3779939D1 (de) Antibakterielle medikamente fuer fische.

Legal Events

Date Code Title Description
NUG Patent has lapsed